If you're looking to bolster your portfolio with some ASX 200 shares, then you might want to consider buying the ones listed below.
Here's why I think they could give most portfolios a boost:
a2 Milk Company Ltd (ASX: A2M)
The first ASX 200 share I would buy is a2 Milk Company. It is a growing infant formula and fresh milk company with a focus on A2-only products. It has been thanks to this point of difference that a2 Milk has stood out from the rest in a crowded market and delivered such strong growth. This has certainly been the case in China where it sales continue to grow rapidly. While FY 2021 looks set to be a rare off-year because of the pandemic, I'm confident it will bounce back strongly in FY 2022 as trading conditions normalise.
Cochlear Limited (ASX: COH)
I think Cochlear would be another great option. It is one of the world's leading hearing solutions companies and has a long track record of delivering earnings growth. I'm confident this positive trend will continue for a long time to come thanks to the ageing populations tailwind. As the over 65 population grows, demand for its hearing solutions is likely to grow along with it.
REA Group Limited (ASX: REA)
REA Group is a digital advertising company that operates Australia's leading property websites. It also operates real estate websites in Europe, Asia, and the United States. While trading conditions are admittedly tough now because of the pandemic, I expect these headwinds to ease once its passes. After which, I believe its earnings growth will accelerate once again. Another positive is the company has recently entered into a binding agreement to take a controlling interest in Elara Technologies. It is the operator of India's fastest growing digital real estate business based on audience size.
Wesfarmers Ltd (ASX: WES)
A final ASX 200 share to consider buying is Wesfarmers. It is the company behind brands such as Bunnings, Kmart, Target, Catch, and Officeworks. It also owns a number chemicals and industrial businesses. And given its strong balance sheet and penchant for earnings accretive acquisitions, I wouldn't be surprised if it added to its portfolio in the near future. If it does, this would give its already very positive long term outlook an extra boost.
